The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
Leadership Calendar: Commissioner Christine S. Wilson- October 2021
Leadership Calendar: Chair Lina M. Khan- October 2021
Dun & Bradstreet, Inc.; Analysis of Proposed Consent Order to Aid Public Comment
Leadership Calendar: Commissioner Christine S. Wilson- September 2021
Leadership Calendar: Chair Lina M. Khan- September 2021
Statement of Chair Lina M. Khan Regarding the Request for Information on Merger Enforcement
Statement of Commissioners Noah Joshua Phillips and Christine S. Wilson Regarding the Request for Information on Merger Enforcement
Commission Statement on the Holder Rule and Attorneys’ Fees and Costs
Leadership Calendar: Commissioner Christine S. Wilson- August 2021
Leadership Calendar: Chair Lina M. Khan- August 2021
Leadership Calendar: Commissioner Christine S. Wilson- July 2021
Leadership Calendar: Chair Lina M. Khan- July 2021
Leadership Calendar: Commissioner Christine S. Wilson- June 2021
Leadership Calendar: Chair Lina M. Khan- June 2021
Leadership Calendar: Commissioner Christine S. Wilson- May 2021
Leadership Calendar: Commissioner Christine S. Wilson- April 2021
Leadership Calendar: Commissioner Christine S. Wilson- March 2021
ANI/Novitium, In the Matter of
The Federal Trade Commission required generic drug marketers ANI Pharmaceuticals, Inc. and Novitium Pharma LLC to divest, to Prasco LLC, ANI’s development rights to one generic drug and assets with respect to another generic drug as part of a settlement resolving charges that ANI’s $210 million acquisition of Novitium likely would be anticompetitive. According to the complaint, without a remedy, the acquisition would likely harm future competition in U.S. markets for both of these generic products. The order requires ANI and Novitium to divest ANI’s rights and assets to generic SMX-TMP oral suspension and generic dexamethasone tablets to Prasco within 10 days after the acquisition is final. On Jan. 12, 2022, the Commission announced the final consent order in this matter.